WO2023156267 - NOVEL BIOMARKERS FOR DIAGNOSING SCHIZOPHRENIA IN EXHALED BREATH
National phase entry is expected:
Publication Number
WO/2023/156267
Publication Date
24.08.2023
International Application No.
PCT/EP2023/053072
International Filing Date
08.02.2023
Title **
[English]
NOVEL BIOMARKERS FOR DIAGNOSING SCHIZOPHRENIA IN EXHALED BREATH
[French]
NOUVEAUX BIOMARQUEURS POUR DIAGNOSTIQUER LA SCHIZOPHRÉNIE DANS L'AIR EXPIRÉ
Applicants **
OTTO-VON-GUERICKE-UNIVERSITÄT MAGDEBURG
Universitätsplatz 2
39106 Magdeburg, DE
Inventors
FRODL, Thomas
Wilhelm-Külzstr. 17
39108 Magdeburg, DE
MEYER-LOTZ, Gabriela
Hansapark 21
39116 Magdeburg, DE
DOBROWOLNY, Henrik
Gartenstraße 6E
39175 Gerwisch, DE
HOESCHEN, Christoph
Bettina-von-Arnim-Straße 8
39114 Magdeburg, DE
Priority Data
22156860.3
15.02.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1086 | |
| EPO | Filing, Examination | 4950 | |
| Japan | Filing | 590 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 2710 |
Total: 9911 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to a method of diagnosing schizophrenia in a patient. Further, the present invention relates to a method of determining the course of schizophrenia in a patient. Furthermore, the present invention relates to a method of determining whether a patient responds to a therapeutic treatment of schizophrenia. In addition, the present invention relates to a device which can be used in these methods. Moreover, the present invention relates to a kit comprising the device.[French]
La présente invention concerne une méthode de diagnostic de la schizophrénie chez un patient. En outre, la présente invention concerne une méthode de détermination de l'évolution de la schizophrénie chez un patient. En outre, la présente invention concerne une méthode de détermination du fait qu'un patient répond à un traitement thérapeutique de la schizophrénie. De plus, la présente invention concerne un dispositif qui peut être utilisé dans ces méthodes. De plus, la présente invention concerne un kit comprenant le dispositif.